The Leadership Team at Minervax drives the strategic vision and direction for the company, ensuring the successful development of its innovative vaccine against Group B Streptococcus. Comprising the CEO, CSO, and CTO, the team focuses on overseeing research initiatives, regulatory compliance, and commercial strategies, while fostering collaboration across departments to achieve milestones in biotechnology development.